164 related articles for article (PubMed ID: 19295023)
1. [Antimicrobial resistance profile of E. coli and Klebsiella spp. from urine in the Infectious Diseases Hospital Iaşi].
Miftode E; Dorneanu O; Leca D; Teodor A; Mihalache D; Filip O; Luca V
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):478-82. PubMed ID: 19295023
[TBL] [Abstract][Full Text] [Related]
2. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
[TBL] [Abstract][Full Text] [Related]
3. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
4. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
[TBL] [Abstract][Full Text] [Related]
6. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
Akyar I
Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
[TBL] [Abstract][Full Text] [Related]
7. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
Matute AJ; Hak E; Schurink CA; McArthur A; Alonso E; Paniagua M; Van Asbeck E; Roskott AM; Froeling F; Rozenberg-Arska M; Hoepelman IM
Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
[TBL] [Abstract][Full Text] [Related]
8. Etiology and antibiotic susceptibility patterns of community-acquired urinary tract infections in a Kuwait hospital.
Dimitrov TS; Udo EE; Emara M; Awni F; Passadilla R
Med Princ Pract; 2004; 13(6):334-9. PubMed ID: 15467308
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
10. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the spectrum and antibiotic resistance of uropathogens in vitro: results based on a retrospective study from a tertiary hospital.
Ma KL; Wang CX
Am J Infect Control; 2013 Jul; 41(7):601-6. PubMed ID: 23352074
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
13. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Huang SS; Lee MH; Leu HS
J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
[TBL] [Abstract][Full Text] [Related]
14. Hospital and community isolates of uropathogens at a tertiary hospital in South Africa.
Habte TM; Dube S; Ismail N; Hoosen AA
S Afr Med J; 2009 Aug; 99(8):584-7. PubMed ID: 19908617
[TBL] [Abstract][Full Text] [Related]
15. [Resistance to fluoroquinolone among Klebsiella spp strains producing extended-spectrum betalactamases isolated from urine].
Tlamçani Z; Ellaia K; Benomar A; Kabbaj H; Alaoui A; Seffar M
Ann Biol Clin (Paris); 2009; 67(5):553-6. PubMed ID: 19789127
[TBL] [Abstract][Full Text] [Related]
16. [Profile of antimicrobial resistance of agents causing urinary tract infections in Chilean children. PRONARES surveillance program].
Prado V; Trucco O; Durán C; Mamani R; Royer M;
Rev Med Chil; 2001 Aug; 129(8):877-85. PubMed ID: 11680961
[TBL] [Abstract][Full Text] [Related]
17. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
[TBL] [Abstract][Full Text] [Related]
18. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
Demir T; Buyukguclu T
Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831
[TBL] [Abstract][Full Text] [Related]
20. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Martinez P; Garzón D; Mattar S
Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
